@ patients affected by knee OA were assessed for eligibility and @ were enrolled and randomized to receive either intra-articular polynucleotides ( Condrotide-@ patients ) or hyaluronic acid ( Hyalubrix-@ patients ) at the Orthopedic Institute `` Gaetano Pini '' ( Milan ) .